Clinical Trials Logo

Filter by:
NCT ID: NCT06005285 Recruiting - Autism Clinical Trials

Examining the Effectiveness of the Early Start Denver Model in Community Programs Serving Young Autism

Start date: March 1, 2024
Phase: N/A
Study type: Interventional

This study tests the effectiveness of the Early Start Denver Model (ESDM) in community agencies that serve young autistic children. The feasibility, usability and acceptability of the model will be explored. Understanding effectiveness of new evidence-based models will increase the quality of autism care available to more diverse children and families in more geographic locations.

NCT ID: NCT06005194 Recruiting - Clinical trials for Depressive Disorder, Major

InMotion - Telehealth Delivered Exercise Promotion to Treat Major Depression After TBI

Start date: November 14, 2023
Phase: N/A
Study type: Interventional

The purpose of this randomized controlled trial is to evaluate whether the InMotion intervention, delivered via telehealth (using a HIPAA-compliant video platform or phone), which uses evidence-based behavioral and motivational counseling to increase daily physical activity, is an effective treatment for Major Depressive Disorder (MDD) for people who are at least one year out from sustaining a traumatic brain injury (TBI). The first aim is to compare the efficacy of the InMotion intervention to the waitlist control (WLC) condition on measures of depression severity and associated conditions in under-active adults with TBI and MDD. For the second aim the investigators plan to identify possible moderators of exercise treatment effects. The third aim will examine possible mediators of treatment outcome. In addition, the weekly dose of exercise, the extent to which exercise generates positive affect, and engagement in enjoyable or meaningful aspects of life will be explored.

NCT ID: NCT06005181 Recruiting - Clinical trials for Fetal Alcohol Spectrum Disorders

The Synchrony Study: Examining Music Training for Children With FASD

Synchrony
Start date: October 2, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to examine if music training improves behavioral or cognitive performance in children with prenatal alcohol exposure who meet research criteria for a fetal alcohol spectrum disorder. The main questions it aims to answer are: - Does music training improve behavioral regulation for children with an FASD - Does music training improve cognitive performance (attention and working memory) for children with an FASD. The study has two interventions for each participant: music listening and piano training. Each participant will either practice piano daily for 12 weeks or listen to pre-selected music daily for 12 weeks. The order of the interventions will be randomized across participants. Assessment will occur before and after participation in each 12 week intervention.

NCT ID: NCT06005168 Recruiting - Clinical trials for Surgical Prophylaxis

Comparison of a Morphomic-Based to the Standard-of-Care-Based Cefazolin Dose for Antimicrobial Prophylaxis

MorphAbxPKSurg
Start date: March 8, 2023
Phase: Phase 4
Study type: Interventional

The goal of this clinical study is to compare the dosing of an antibiotic in overweight patients having surgery. The main question[s] it aims to answer are: - Are the antibiotic concentrations in blood and fat tissue in patients that are overweight sufficient to prevent the chance of infection? - Can dosing using body composition rather than body weight improve the chance of achieving good antibiotic concentrations in overweight patients? Participants will allow us to collect small amounts of blood and fat tissue during their regularly scheduled surgery. Researchers will compare differences in antibiotic concentrations based on dosing by standard of care (body weight based) versus body composition.

NCT ID: NCT06005129 Recruiting - Clinical trials for Borderline Personality Disorder

Personality Change Study for Borderline Personality Disorder

Start date: September 15, 2023
Phase: N/A
Study type: Interventional

Participants with borderline personality disorder will undergo an a 2 - 4 week baseline assessment to determine level of outcomes of interest in the absence of treatment. After the baseline period, participants will receive six weekly 50-60-minute treatment sessions. After the 6 treatment sessions, participants will complete a 4-week follow-up period to determine the sustainability of the treatment module.

NCT ID: NCT06005051 Not yet recruiting - Clinical trials for Diabetes Mellitus, Type 2

Prediabetes Stratification by Multi-omics Profile After Food Intake

Start date: May 1, 2024
Phase: N/A
Study type: Interventional

1 in 3 adults have prediabetes in the United States, and many of them will eventually develop diabetes, which has significant public health and economic costs. However, type 2 diabetes (T2D) and prediabetes are heterogeneous groups with different pathological mechanisms, dysfunctions in different processes, and varied disease trajectories. Patient stratifications into subtypes and personalized nutrition interventions are highly needed but not yet available. Metabolic responses (e.g., glucose excursion) after food intake provide a direct observation of personal metabolic control and its association with T2D. The investigators hope to learn how prediabetes and type 2 diabetes evolve, and specifically what food or exercise can do to mitigate blood sugar response.

NCT ID: NCT06005038 Recruiting - Clinical trials for Mild Cognitive Impairment

CogT pSOPT Intervention Study

Start date: January 12, 2024
Phase: Phase 1
Study type: Interventional

(JUSTIFICATION: This is the R33 stage of an NIH funded R21/R33 study. R21 stage (IRB-61727) was focused on intervention development; R33 stage will focus on pilot testing the effect of the intervention. The R21 phase was not considered a NIH defined clinical trial; R33 will be considered a NIH defined clinical trial) The purpose is to develop and test the effect of a "personalized" computer-based cognitive training program. The personalized program tailors the difficulty of the training tasks using a participant's biofeedback (i.e., heart rate) and cognitive performance. Such a personalization will ensure that the participant can perform at his/her ideal training capacity. Participants will be randomized into one of 2 groups and each group will play a different version of computerized training game and have ECG collected to allow subject blinding.

NCT ID: NCT06005012 Recruiting - Clinical trials for Non-Alcoholic Fatty Liver Disease

Semaglutide Treatment in the Real-world for Fibrosis Due to NAFLD in Obesity and T2DM

SAMARA
Start date: July 25, 2023
Phase: Phase 2
Study type: Interventional

Conduct a community intervention study that will 1) validate a screening approach to identify patients at risk for advanced NAFLD in the obese or T2DM population, and 2) test whether semaglutide treatment is effective for the management of significant fibrosis due to NAFLD in high-risk patients.

NCT ID: NCT06004973 Recruiting - Healthy Clinical Trials

Aldena STAR Particles

Start date: February 7, 2024
Phase: N/A
Study type: Interventional

The objective of this study is to find out the best method of applying STAR particles to the skin. STAR particles are very small particles with microneedles on the surface that can increase and create small punctures in the skin. The small punctures should allow for different topical medications to work more effectively. This is important to understand the potential use of STAR particles in future topical medications. This study will not use any medication with active ingredients. The study will include healthy adult participants. The first visit will be for the collection of medical information and assessing eligibility in the study. The second visit will have the application of STAR particles on different areas of the arm and hand with different pressures to see what the most effective method of application is. The skin will be evaluated after the application and surveys will be collected on the tolerability of the application.

NCT ID: NCT06004960 Completed - Clinical trials for Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis

A Study to Assess the Mass Balance Recovery (Absorption, Distribution, Metabolism and Excretion) of [14C]CCX168 in Healthy Participants

Start date: October 20, 2014
Phase: Phase 1
Study type: Interventional

The primary objective of this study is to perform mass balance following a single oral dose of [14C]CCX168 in healthy adult male participants.